FDA Reports Finding Cancer Causing Substances in Johnson & Johnson Baby Powder
Food and Drug Administration (FDA), reportedly suspended the licence of Johnson & Johnson.
As per the reports, the order was issued in a case dating back to 2007 when residues of carcinogenic substances were found in 15 batches of Johnson & Johnson baby powder. And later it was found out that the residue was found because that the talcum powder was sterilized by ethylene oxide which in is carcinogenic and irritant.
As per the reports, the order will become effective from 24 June.
ALSO:
An Arkansas judge fined Johnson & Johnson and a subsidiary more than $1.1 billion Wednesday April 12, 2013 for downplaying and concealing risks associated with the antipsychotic drug Risperdal, a ruling that could affect dozens of pending lawsuits over the drug.
Circuit Judge Tim Fox ruled that Janssen Pharmaceuticals Inc. and its parent company must pay $5,000 for each of 240,000 Risperdal prescriptions the state health coverage program paid for during a 3½-year period, accounting for the bulk of the penalty.
A jury on Tuesday April 11, 2013 found the companies liable.
The post FDA Reports Finding Cancer Causing Substances in Johnson & Johnson Baby Powder appeared first on .
\”survive the economic fallout of hyperinflation. Find out more at MorningStarCoins.com\”
2013-05-02 11:34:21
Source:
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
| Online: | |
| Visits: | 1,688,896,563 |
| Stories: | 8,394,305 |
Whistler Blowers, Insiders
Note: The FDA of India suspended the cosmetic license of one plant in India. This report was not about the US FDA.